Table of Content

1 Report Overview
1.1 Viral Vaccines Definition
1.2 Market by Type
1.2.1 Global Viral Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Market Segment by Application
1.3.1 Global Viral Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Viral Vaccines Sales
2.1 Global Viral Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Viral Vaccines Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Viral Vaccines Revenue by Region
2.3.1 Global Viral Vaccines Revenue by Region (2018-2023)
2.3.2 Global Viral Vaccines Revenue by Region (2024-2034)
2.4 Global Viral Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Viral Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Viral Vaccines Sales Quantity by Region
2.6.1 Global Viral Vaccines Sales Quantity by Region (2018-2023)
2.6.2 Global Viral Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Viral Vaccines Sales Quantity by Manufacturers
3.1.1 Global Viral Vaccines Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Viral Vaccines Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Viral Vaccines Sales in 2024
3.2 Global Viral Vaccines Revenue by Manufacturers
3.2.1 Global Viral Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Viral Vaccines Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2024
3.3 Global Viral Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Viral Vaccines, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Viral Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Viral Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Viral Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Viral Vaccines Sales Quantity by Type
4.1.1 Global Viral Vaccines Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Viral Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Viral Vaccines Revenue by Type
4.2.1 Global Viral Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Viral Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Viral Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Viral Vaccines Price by Type
4.3.1 Global Viral Vaccines Price by Type (2018-2023)
4.3.2 Global Viral Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Viral Vaccines Sales Quantity by Application
5.1.1 Global Viral Vaccines Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Viral Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Viral Vaccines Revenue by Application
5.2.1 Global Viral Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Viral Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Viral Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Viral Vaccines Price by Application
5.3.1 Global Viral Vaccines Price by Application (2018-2023)
5.3.2 Global Viral Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Viral Vaccines Sales by Company
6.1.1 North America Viral Vaccines Revenue by Company (2018-2023)
6.1.2 North America Viral Vaccines Sales Quantity by Company (2018-2023)
6.2 North America Viral Vaccines Market Size by Type
6.2.1 North America Viral Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Viral Vaccines Revenue by Type (2018-2034)
6.3 North America Viral Vaccines Market Size by Application
6.3.1 North America Viral Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Viral Vaccines Revenue by Application (2018-2034)
6.4 North America Viral Vaccines Market Size by Country
6.4.1 North America Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Viral Vaccines Revenue by Country (2018-2034)
6.4.3 North America Viral Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Viral Vaccines Sales by Company
7.1.1 Europe Viral Vaccines Sales Quantity by Company (2018-2023)
7.1.2 Europe Viral Vaccines Revenue by Company (2018-2023)
7.2 Europe Viral Vaccines Market Size by Type
7.2.1 Europe Viral Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Viral Vaccines Revenue by Type (2018-2034)
7.3 Europe Viral Vaccines Market Size by Application
7.3.1 Europe Viral Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Viral Vaccines Revenue by Application (2018-2034)
7.4 Europe Viral Vaccines Market Size by Country
7.4.1 Europe Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Viral Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Viral Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Viral Vaccines Sales by Company
8.1.1 China Viral Vaccines Sales Quantity by Company (2018-2023)
8.1.2 China Viral Vaccines Revenue by Company (2018-2023)
8.2 China Viral Vaccines Market Size by Type
8.2.1 China Viral Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Viral Vaccines Revenue by Type (2018-2034)
8.3 China Viral Vaccines Market Size by Application
8.3.1 China Viral Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Viral Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Viral Vaccines Sales by Company
9.1.1 APAC Viral Vaccines Sales Quantity by Company (2018-2023)
9.1.2 APAC Viral Vaccines Revenue by Company (2018-2023)
9.2 APAC Viral Vaccines Market Size by Type
9.2.1 APAC Viral Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Viral Vaccines Revenue by Type (2018-2034)
9.3 APAC Viral Vaccines Market Size by Application
9.3.1 APAC Viral Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Viral Vaccines Revenue by Application (2018-2034)
9.4 APAC Viral Vaccines Market Size by Region
9.4.1 APAC Viral Vaccines Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Viral Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Viral Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Viral Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Viral Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Viral Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Viral Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 GSK Viral Vaccines Products and Services
11.1.5 GSK Viral Vaccines SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Merck Viral Vaccines Products and Services
11.2.5 Merck Viral Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Novartis Viral Vaccines Products and Services
11.3.5 Novartis Viral Vaccines SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Pfizer Viral Vaccines Products and Services
11.4.5 Pfizer Viral Vaccines SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Sanofi Viral Vaccines Products and Services
11.5.5 Sanofi Viral Vaccines SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Overview
11.6.3 Bayer Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Bayer Viral Vaccines Products and Services
11.6.5 Bayer Viral Vaccines SWOT Analysis
11.6.6 Bayer Recent Developments
11.7 Zoetis
11.7.1 Zoetis Company Information
11.7.2 Zoetis Overview
11.7.3 Zoetis Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Zoetis Viral Vaccines Products and Services
11.7.5 Zoetis Viral Vaccines SWOT Analysis
11.7.6 Zoetis Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 AstraZeneca Viral Vaccines Products and Services
11.8.5 AstraZeneca Viral Vaccines SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 Johnson
11.9.1 Johnson Company Information
11.9.2 Johnson Overview
11.9.3 Johnson Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Johnson Viral Vaccines Products and Services
11.9.5 Johnson Viral Vaccines SWOT Analysis
11.9.6 Johnson Recent Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Overview
11.10.3 CSL Viral Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 CSL Viral Vaccines Products and Services
11.10.5 CSL Viral Vaccines SWOT Analysis
11.10.6 CSL Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Viral Vaccines Value Chain Analysis
12.2 Viral Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viral Vaccines Production Mode & Process
12.4 Viral Vaccines Sales and Marketing
12.4.1 Viral Vaccines Sales Channels
12.4.2 Viral Vaccines Distributors
12.5 Viral Vaccines Customers
13 Market Dynamics
13.1 Viral Vaccines Industry Trends
13.2 Viral Vaccines Market Drivers
13.3 Viral Vaccines Market Challenges
13.4 Viral Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Viral Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Attenuated Vaccine
Table 3. Major Manufacturers of Inactivated Vaccine
Table 4. Global Viral Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Viral Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Viral Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Viral Vaccines Revenue Market Share by Region (2018-2023)
Table 8. Global Viral Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Viral Vaccines Revenue Market Share by Region (2024-2034)
Table 10. Global Viral Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 11. Global Viral Vaccines Sales by Region (2018-2023) & (K MT)
Table 12. Global Viral Vaccines Sales Market Share by Region (2018-2023)
Table 13. Global Viral Vaccines Sales by Region (2024-2034) & (K MT)
Table 14. Global Viral Vaccines Sales Market Share by Region (2024-2034)
Table 15. Global Viral Vaccines Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 16. Global Viral Vaccines Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Viral Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Viral Vaccines Revenue Share by Manufacturers (2018-2023)
Table 19. Global Viral Vaccines Price by Manufacturers 2018-2023 (USD/MT)
Table 20. Global Key Players of Viral Vaccines, Industry Ranking, 2021 VS 2024
Table 21. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2024)
Table 23. Global Key Manufacturers of Viral Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Viral Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Viral Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 28. Global Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 29. Global Viral Vaccines Sales Quantity Share by Type (2018-2023)
Table 30. Global Viral Vaccines Sales Quantity Share by Type (2024-2034)
Table 31. Global Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Viral Vaccines Revenue Share by Type (2018-2023)
Table 34. Global Viral Vaccines Revenue Share by Type (2024-2034)
Table 35. Viral Vaccines Price by Type (2018-2023) & (USD/MT)
Table 36. Global Viral Vaccines Price Forecast by Type (2024-2034) & (USD/MT)
Table 37. Global Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 38. Global Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 39. Global Viral Vaccines Sales Quantity Share by Application (2018-2023)
Table 40. Global Viral Vaccines Sales Quantity Share by Application (2024-2034)
Table 41. Global Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Viral Vaccines Revenue Share by Application (2018-2023)
Table 44. Global Viral Vaccines Revenue Share by Application (2024-2034)
Table 45. Viral Vaccines Price by Application (2018-2023) & (USD/MT)
Table 46. Global Viral Vaccines Price Forecast by Application (2024-2034) & (USD/MT)
Table 47. North America Viral Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Viral Vaccines Sales Quantity by Company (2018-2023) & (K MT)
Table 49. North America Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 50. North America Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 51. North America Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 54. North America Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 55. North America Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Viral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Viral Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Viral Vaccines Sales Quantity by Country (2018-2023) & (K MT)
Table 61. North America Viral Vaccines Sales Quantity by Country (2024-2034) & (K MT)
Table 62. Europe Viral Vaccines Sales Quantity by Company (2018-2023) & (K MT)
Table 63. Europe Viral Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 65. Europe Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 66. Europe Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 69. Europe Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 70. Europe Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Viral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Viral Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Viral Vaccines Sales Quantity by Country (2018-2023) & (K MT)
Table 76. Europe Viral Vaccines Sales Quantity by Country (2024-2034) & (K MT)
Table 77. China Viral Vaccines Sales Quantity by Company (2018-2023) & (K MT)
Table 78. China Viral Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 80. China Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 81. China Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 84. China Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 85. China Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Viral Vaccines Sales Quantity by Company (2018-2023) & (K MT)
Table 88. APAC Viral Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 90. APAC Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 91. APAC Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 94. APAC Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 95. APAC Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Viral Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Viral Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Viral Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Viral Vaccines Sales Quantity by Region (2018-2023) & (K MT)
Table 101. APAC Viral Vaccines Sales Quantity by Region (2024-2034) & (K MT)
Table 102. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Company (2018-2023) & (K MT)
Table 103. Middle East, Africa and Latin America Viral Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Type (2018-2023) & (K MT)
Table 105. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Type (2024-2034) & (K MT)
Table 106. Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Viral Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Application (2018-2023) & (K MT)
Table 109. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Application (2024-2034) & (K MT)
Table 110. Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Viral Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Viral Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Viral Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Country (2018-2023) & (K MT)
Table 116. Middle East, Africa and Latin America Viral Vaccines Sales Quantity by Country (2024-2034) & (K MT)
Table 117. GSK Company Information
Table 118. GSK Description and Overview
Table 119. GSK Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 120. GSK Viral Vaccines Product and Services
Table 121. GSK Viral Vaccines SWOT Analysis
Table 122. GSK Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Overview
Table 125. Merck Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 126. Merck Viral Vaccines Product and Services
Table 127. Merck Viral Vaccines SWOT Analysis
Table 128. Merck Recent Developments
Table 129. Novartis Company Information
Table 130. Novartis Description and Overview
Table 131. Novartis Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 132. Novartis Viral Vaccines Product and Services
Table 133. Novartis Viral Vaccines SWOT Analysis
Table 134. Novartis Recent Developments
Table 135. Pfizer Company Information
Table 136. Pfizer Description and Overview
Table 137. Pfizer Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 138. Pfizer Viral Vaccines Product and Services
Table 139. Pfizer Viral Vaccines SWOT Analysis
Table 140. Pfizer Recent Developments
Table 141. Sanofi Company Information
Table 142. Sanofi Description and Overview
Table 143. Sanofi Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 144. Sanofi Viral Vaccines Product and Services
Table 145. Sanofi Viral Vaccines SWOT Analysis
Table 146. Sanofi Recent Developments
Table 147. Bayer Company Information
Table 148. Bayer Description and Overview
Table 149. Bayer Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 150. Bayer Viral Vaccines Product and Services
Table 151. Bayer Viral Vaccines SWOT Analysis
Table 152. Bayer Recent Developments
Table 153. Zoetis Company Information
Table 154. Zoetis Description and Overview
Table 155. Zoetis Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 156. Zoetis Viral Vaccines Product and Services
Table 157. Zoetis Viral Vaccines SWOT Analysis
Table 158. Zoetis Recent Developments
Table 159. AstraZeneca Company Information
Table 160. AstraZeneca Description and Overview
Table 161. AstraZeneca Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 162. AstraZeneca Viral Vaccines Product and Services
Table 163. AstraZeneca Viral Vaccines SWOT Analysis
Table 164. AstraZeneca Recent Developments
Table 165. Johnson Company Information
Table 166. Johnson Description and Overview
Table 167. Johnson Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 168. Johnson Viral Vaccines Product and Services
Table 169. Johnson Viral Vaccines SWOT Analysis
Table 170. Johnson Recent Developments
Table 171. CSL Company Information
Table 172. CSL Description and Overview
Table 173. CSL Viral Vaccines Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 174. CSL Viral Vaccines Product and Services
Table 175. CSL Viral Vaccines SWOT Analysis
Table 176. CSL Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Viral Vaccines Distributors List
Table 180. Viral Vaccines Customers List
Table 181. Viral Vaccines Market Trends
Table 182. Viral Vaccines Market Drivers
Table 183. Viral Vaccines Market Challenges
Table 184. Viral Vaccines Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 2. Global Viral Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Viral Vaccines Market Share by Type in 2024 & 2034
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Viral Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Viral Vaccines Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Pharmaceutical Factory
Figure 10. Research Institute
Figure 11. Others
Figure 12. Viral Vaccines Report Years Considered
Figure 13. Global Viral Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Viral Vaccines Revenue 2018-2034 (US$ Million)
Figure 15. Global Viral Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Viral Vaccines Sales Quantity 2018-2034 (K MT)
Figure 17. Global Viral Vaccines Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Viral Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Viral Vaccines Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. North America Viral Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Viral Vaccines Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. Europe Viral Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Viral Vaccines Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. China Viral Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Viral Vaccines Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. APAC Viral Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Viral Vaccines Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. Middle East, Africa and Latin America Viral Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Viral Vaccines Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Viral Vaccines Revenue in 2024
Figure 31. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 34. Global Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 36. North America Viral Vaccines Revenue Market Share by Company in 2024
Figure 37. North America Viral Vaccines Sales Quantity Market Share by Company in 2024
Figure 38. North America Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. North America Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America Viral Vaccines Revenue Share by Country (2018-2034)
Figure 43. North America Viral Vaccines Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Viral Vaccines Sales Quantity Market Share by Company in 2024
Figure 47. Europe Viral Vaccines Revenue Market Share by Company in 2024
Figure 48. Europe Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 50. Europe Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 52. Europe Viral Vaccines Revenue Share by Country (2018-2034)
Figure 53. Europe Viral Vaccines Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. France Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. China Viral Vaccines Sales Quantity Market Share by Company in 2024
Figure 60. China Viral Vaccines Revenue Market Share by Company in 2024
Figure 61. China Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 63. China Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 65. APAC Viral Vaccines Sales Quantity Market Share by Company in 2024
Figure 66. APAC Viral Vaccines Revenue Market Share by Company in 2024
Figure 67. APAC Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. APAC Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC Viral Vaccines Revenue Share by Region (2018-2034)
Figure 72. APAC Viral Vaccines Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. India Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Viral Vaccines Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Viral Vaccines Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Viral Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Viral Vaccines Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Viral Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Viral Vaccines Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Viral Vaccines Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Viral Vaccines Revenue Share by Country (2018-2034)
Figure 86. Brazil Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Viral Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Viral Vaccines Value Chain
Figure 92. Viral Vaccines Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed